Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

62 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Accuracy of Xpert and alternative sampling methods to diagnose childhood pulmonary tuberculosis, a prospective cohort study.
Macaux L, Rasolofo V, Eyangoh S, N'Guessan KR, Tejiokem MC, Rakotosamimanana N, Soumahoro MK, Cauchemez S, Randremanana RV; TB-KIDS study group. Macaux L, et al. Among authors: tejiokem mc. Clin Microbiol Infect. 2024 Nov 8:S1198-743X(24)00528-7. doi: 10.1016/j.cmi.2024.11.002. Online ahead of print. Clin Microbiol Infect. 2024. PMID: 39522607 Free article.
A multicountry evaluation of the Xpert MTB/RIF assay for the diagnosis of intrathoracic tuberculosis in children using alternative specimens (nasopharyngeal aspirate and stool): A prospective cohort study conducted in Madagascar, Ivory Coast and Cameroon (TB KIDS project).
Randremanana RV, Tejiokem M, Rakotosamimanana N, Donfack VD, Mbouchong VB, Randrianarisoa M, Harimanana A, Taguebue JV, Ndiang ST, Itchy V, Robinson A, Ravelomanana L, Rakotomahefa M, Ranoharison D, Soumahoro MK, Gicquel B, N'Guessan R, Eyangoh S, Rasolofo V; TB-KIDS Study group. Randremanana RV, et al. Int J Infect Dis. 2025 Feb;151:107366. doi: 10.1016/j.ijid.2024.107366. Epub 2024 Dec 16. Int J Infect Dis. 2025. PMID: 39694229 Free article.
Mortality and its determinants in antiretroviral treatment-naive HIV-infected children with suspected tuberculosis: an observational cohort study.
Marcy O, Tejiokem M, Msellati P, Truong Huu K, Do Chau V, Tran Ngoc D, Nacro B, Ateba-Ndongo F, Tetang-Ndiang S, Ung V, Dim B, Neou L, Berteloot L, Borand L, Delacourt C, Blanche S; ANRS 12229 PAANTHER 01 Study Group. Marcy O, et al. Lancet HIV. 2018 Feb;5(2):e87-e95. doi: 10.1016/S2352-3018(17)30206-0. Epub 2017 Nov 23. Lancet HIV. 2018. PMID: 29174612 Clinical Trial.
Epidemiology of methicillin-resistant Staphylococcus aureus lineages in five major African towns: emergence and spread of atypical clones.
Breurec S, Zriouil SB, Fall C, Boisier P, Brisse S, Djibo S, Etienne J, Fonkoua MC, Perrier-Gros-Claude JD, Pouillot R, Ramarokoto CE, Randrianirina F, Tall A, Thiberge JM; Working Group on Staphylococcus aureus infections; Laurent F, Garin B. Breurec S, et al. Clin Microbiol Infect. 2011 Feb;17(2):160-5. doi: 10.1111/j.1469-0691.2010.03219.x. Clin Microbiol Infect. 2011. PMID: 20298267 Free article.
Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in adults in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trial.
Tapia MD, Sow SO, Ndiaye BP, Mbaye KD, Thiongane A, Ndour CT, Mboup S, Ake JA, Keshinro B, Akintunde GA, Kinge TN, Vernet G, Bigna JJ, Oguche S, Koram KA, Asante KP, Hogrefe WR, Günther S, Naficy A, De Ryck I, Debois M, Bourguignon P, Jongert E, Ballou WR, Koutsoukos M, Roman F; Zaire EBola Research Alliance group. Tapia MD, et al. Lancet Infect Dis. 2020 Jun;20(6):707-718. doi: 10.1016/S1473-3099(20)30016-5. Epub 2020 Mar 19. Lancet Infect Dis. 2020. PMID: 32199491 Clinical Trial.
Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in children in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trial.
Tapia MD, Sow SO, Mbaye KD, Thiongane A, Ndiaye BP, Ndour CT, Mboup S, Keshinro B, Kinge TN, Vernet G, Bigna JJ, Oguche S, Koram KA, Asante KP, Gobert P, Hogrefe WR, De Ryck I, Debois M, Bourguignon P, Jongert E, Ballou WR, Koutsoukos M, Roman F; Zaire EBola Research Alliance group. Tapia MD, et al. Lancet Infect Dis. 2020 Jun;20(6):719-730. doi: 10.1016/S1473-3099(20)30019-0. Epub 2020 Mar 19. Lancet Infect Dis. 2020. PMID: 32199492 Clinical Trial.
A community-based peer-facilitated psychological and social support model to improve retention in care among Cameroonian adolescents perinatally infected with human immunodeficiency virus: A randomized controlled trial.
Ndongo FA, Noah JYA, Kana R, Ndie J, Nono M, Ndzie P, Tejiokem MC, Biheng EH, Nkoa TA, Coulibaly YA, Fokam J, Ketchaji A, Ngako JN, Penda CI, Ndombo POK, Hawa HM, Msellati P, Faye A, Lallemant M, Bissek ACZ. Ndongo FA, et al. Among authors: tejiokem mc. J Epidemiol Popul Health. 2024 Dec;72(6):202792. doi: 10.1016/j.jeph.2024.202792. Epub 2024 Oct 30. J Epidemiol Popul Health. 2024. PMID: 39476433 Clinical Trial.
Partial spike gene sequencing for the identification of SARS-CoV-2 variants circulating in Cameroon in 2021.
Monamele CG, Sadeuh-Mba SA, Ilouga PV, Moumbeket MHY, Messanga LLE, Mounchili Njifon A, Madaha EL, Njankouo RM, Tagnouokam-Ngoupo PA, Tchatchueng JBM, Tejiokem MC, Perraut R, Eyangoh S, Njouom R. Monamele CG, et al. Among authors: tejiokem mc. J Infect Dev Ctries. 2024 May 30;18(5):701-709. doi: 10.3855/jidc.18155. J Infect Dev Ctries. 2024. PMID: 38865404 Free article.
SARS-CoV-2 Neutralizing Antibodies in Three African Countries Following Multiple Distinct Immune Challenges.
Ny Mioramalala DJ, Ratovoson R, Tagnouokam-Ngoupo PA, Abessolo Abessolo H, Mindimi Nkodo JM, Bouting Mayaka G, Tsoungui Atangana PC, Randrianarisaona F, Pélembi P, Nzoumbou-Boko R, Coti-Reckoundji CSG, Manirakiza A, Rahantamalala A, Randremanana RV, Tejiokem MC, Schoenhals M. Ny Mioramalala DJ, et al. Among authors: tejiokem mc. Vaccines (Basel). 2024 Mar 27;12(4):363. doi: 10.3390/vaccines12040363. Vaccines (Basel). 2024. PMID: 38675745 Free PMC article.
62 results